United States Polypeptide Drug Market Report 2016

United States Polypeptide Drug Market Report 2016

1 Polypeptide Drug Overview

1.1 Product Overview and Scope of Polypeptide Drug

1.2 Classification of Polypeptide Drug

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Polypeptide Drug

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Polypeptide Drug (2011-2021)

1.4.1 United States Polypeptide Drug Sales and Growth Rate (2011-2021)

1.4.2 United States Polypeptide Drug Revenue and Growth Rate (2011-2021)

2 United States Polypeptide Drug Competition by Manufacturers

2.1 United States Polypeptide Drug Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Polypeptide Drug Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Polypeptide Drug Average Price by Manufactures (2015 and 2016)

2.4 Polypeptide Drug Market Competitive Situation and Trends

2.4.1 Polypeptide Drug Market Concentration Rate

2.4.2 Polypeptide Drug Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Polypeptide Drug Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Polypeptide Drug Sales and Market Share by Type (2011-2016)

3.2 United States Polypeptide Drug Revenue and Market Share by Type (2011-2016)

3.3 United States Polypeptide Drug Price by Type (2011-2016)

3.4 United States Polypeptide Drug Sales Growth Rate by Type (2011-2016)

4 United States Polypeptide Drug Sales (Volume) by Application (2011-2016)

4.1 United States Polypeptide Drug Sales and Market Share by Application (2011-2016)

4.2 United States Polypeptide Drug Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Polypeptide Drug Manufacturers Profiles/Analysis

5.1 Novartis

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Polypeptide Drug Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Novartis Polypeptide Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Merck Serono

5.2.2 Polypeptide Drug Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Merck Serono Polypeptide Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Ferring Pharmaceuticals

5.3.2 Polypeptide Drug Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Ferring Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Ipsen PHarma Biotech

5.4.2 Polypeptide Drug Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Ipsen PHarma Biotech Polypeptide Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Lilly

5.5.2 Polypeptide Drug Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Lilly Polypeptide Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Asahi Kasei

5.6.2 Polypeptide Drug Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Asahi Kasei Polypeptide Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 AstraZeneca

5.7.2 Polypeptide Drug Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 AstraZeneca Polypeptide Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 SciClone Pharmaceuticals

5.8.2 Polypeptide Drug Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 SciClone Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Takeda

5.9.2 Polypeptide Drug Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Takeda Polypeptide Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

6 Polypeptide Drug Manufacturing Cost Analysis

6.1 Polypeptide Drug Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Polypeptide Drug

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Polypeptide Drug Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Polypeptide Drug Market Forecast (2016-2021)

10.1 United States Polypeptide Drug Sales, Revenue Forecast (2016-2021)

10.2 United States Polypeptide Drug Sales Forecast by Type (2016-2021)

10.3 United States Polypeptide Drug Sales Forecast by Application (2016-2021)

10.4 Polypeptide Drug Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Polypeptide Drug

Table Classification of Polypeptide Drug

Figure United States Sales Market Share of Polypeptide Drug by Type in 2015

Table Application of Polypeptide Drug

Figure United States Sales Market Share of Polypeptide Drug by Application in 2015

Figure United States Polypeptide Drug Sales and Growth Rate (2011-2021)

Figure United States Polypeptide Drug Revenue and Growth Rate (2011-2021)

Table United States Polypeptide Drug Sales of Key Manufacturers (2015 and 2016)

Table United States Polypeptide Drug Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Polypeptide Drug Sales Share by Manufacturers

Figure 2016 Polypeptide Drug Sales Share by Manufacturers

Table United States Polypeptide Drug Revenue by Manufacturers (2015 and 2016)

Table United States Polypeptide Drug Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Polypeptide Drug Revenue Share by Manufacturers

Table 2016 United States Polypeptide Drug Revenue Share by Manufacturers

Table United States Market Polypeptide Drug Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Polypeptide Drug Average Price of Key Manufacturers in 2015

Figure Polypeptide Drug Market Share of Top 3 Manufacturers

Figure Polypeptide Drug Market Share of Top 5 Manufacturers

Table United States Polypeptide Drug Sales by Type (2011-2016)

Table United States Polypeptide Drug Sales Share by Type (2011-2016)

Figure United States Polypeptide Drug Sales Market Share by Type in 2015

Table United States Polypeptide Drug Revenue and Market Share by Type (2011-2016)

Table United States Polypeptide Drug Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Polypeptide Drug by Type (2011-2016)

Table United States Polypeptide Drug Price by Type (2011-2016)

Figure United States Polypeptide Drug Sales Growth Rate by Type (2011-2016)

Table United States Polypeptide Drug Sales by Application (2011-2016)

Table United States Polypeptide Drug Sales Market Share by Application (2011-2016)

Figure United States Polypeptide Drug Sales Market Share by Application in 2015

Table United States Polypeptide Drug Sales Growth Rate by Application (2011-2016)

Figure United States Polypeptide Drug Sales Growth Rate by Application (2011-2016)

Table Novartis Basic Information List

Table Novartis Polypeptide Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis Polypeptide Drug Sales Market Share (2011-2016)

Table Merck Serono Basic Information List

Table Merck Serono Polypeptide Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck Serono Polypeptide Drug Sales Market Share (2011-2016)

Table Ferring Pharmaceuticals Basic Information List

Table Ferring Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Ferring Pharmaceuticals Polypeptide Drug Sales Market Share (2011-2016)

Table Ipsen PHarma Biotech Basic Information List

Table Ipsen PHarma Biotech Polypeptide Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Ipsen PHarma Biotech Polypeptide Drug Sales Market Share (2011-2016)

Table Lilly Basic Information List

Table Lilly Polypeptide Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Lilly Polypeptide Drug Sales Market Share (2011-2016)

Table Asahi Kasei Basic Information List

Table Asahi Kasei Polypeptide Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Asahi Kasei Polypeptide Drug Sales Market Share (2011-2016)

Table AstraZeneca Basic Information List

Table AstraZeneca Polypeptide Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table AstraZeneca Polypeptide Drug Sales Market Share (2011-2016)

Table SciClone Pharmaceuticals Basic Information List

Table SciClone Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table SciClone Pharmaceuticals Polypeptide Drug Sales Market Share (2011-2016)

Table Takeda Basic Information List

Table Takeda Polypeptide Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Takeda Polypeptide Drug Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Polypeptide Drug

Figure Manufacturing Process Analysis of Polypeptide Drug

Figure Polypeptide Drug Industrial Chain Analysis

Table Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2015

Table Major Buyers of Polypeptide Drug

Table Distributors/Traders List

Figure United States Polypeptide Drug Production and Growth Rate Forecast (2016-2021)

Figure United States Polypeptide Drug Revenue and Growth Rate Forecast (2016-2021)

Table United States Polypeptide Drug Production Forecast by Type (2016-2021)

Table United States Polypeptide Drug Consumption Forecast by Application (2016-2021)